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Dynamic Contrast Enhanced MRI Parameters and Tumor
Cellularity in a Rat Model of Cerebral Glioma at 7 T
Madhava P. Aryal,1,2 Tavarekere N. Nagaraja,3 Kelly A. Keenan,3
Hassan Bagher-Ebadian,1,4 Swayamprava Panda,2 Stephen L. Brown,5
Glauber Cabral,2 Joseph D. Fenstermacher,3,6 and James R. Ewing1,2*
Purpose: To test the hypothesis that a noninvasive dynamic
contrast enhanced MRI (DCE-MRI) derived interstitial volume
fraction (ve) and/or distribution volume (VD) were correlated
with tumor cellularity in cerebral tumor.
Methods: T1-weighted DCE-MRI studies were performed in 18
athymic rats implanted with U251 xenografts. After DCE-MRI,
sectioned brain tissues were stained with Hematoxylin and
Eosin for cell counting. Using a Standard Model analysis and
Logan graphical plot, DCE-MRI image sets during and after
the injection of a gadolinium contrast agent were used to estimate the parameters plasma volume (vp), forward transfer constant (Ktrans), ve, and VD.
Results: Parameter values in regions where the standard
model was selected as the best model were: (mean 6 S.D.):
vp ¼ (0.81 6 0.40)%, Ktrans ¼ (2.09 6 0.65)  102 min1, ve
¼ (6.65 6 1.86)%, and VD ¼ (7.21 6 1.98)%. The Loganestimated VD was strongly correlated with the standard model’s vp þ ve (r ¼ 0.91, P < 0.001). The parameters, ve and/or
VD, were significantly correlated with tumor cellularity (r 
0.75, P < 0.001 for both).
Conclusion: These data suggest that tumor cellularity can be
estimated noninvasively by DCE-MRI, thus supporting its utility
in assessing tumor pathophysiology. Magn Reson Med
C 2013 Wiley Periodicals, Inc.
71:2206–2214, 2014. V
Key words: dual-echo gradient-echo sequence; longitudinal
relaxation rate; DCE-MRI; Logan plot; interstitial volume; distribution volume; tumor cellularity

Dynamic contrast enhanced MRI (DCE-MRI), because it
is minimally invasive and free of radiation exposure, is
becoming the technique of choice for assessing cerebral
vascular permeability (1). A series of T1-weighted images
are acquired before, during, and after the injection of a
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contrast agent (CA), and a pharmacokinetic model is
used to estimate blood-to-brain transfer parameters.
The microvascular leakage of a CA can be parameterized by its plasma volume (vp), forward transvascular
transfer constant (the rate of vessel-to-tissue leakage of
the CA) Ktrans, and, if the leakage occurs swiftly enough,
by the CA’s reverse transfer constant (the rate of tissueto-vessel CA return), kep (2–6). If there are no active
transport mechanisms, and no trapping of CA in either
vascular or extravascular compartments, and when all
three parameters (vp, Ktrans, and kep) can be stably estimated, the derivation of the interstitial volume fraction,
trans
ve, then follows the relationship: ve ¼ Kkep .
While the use of graphical methods for estimating
model parameters has decreased in proportion to the
availability of modern computers, graphical methods’ utility for examining model plausibility remains. Two commonly applied graphical methods in concentration-time
studies are the Patlak plot (2), and Logan plot (7,8). The
Patlak plot was introduced in MRI (9) to estimate Ktrans in
a rat model of transient cerebral ischemia, and the
extended Patlak method (3) has been used in a rat model
of cerebral tumor (9). This latter method, or the equivalent
extended Tofts model (4), also known as the standard
model (SM), is now frequently used for the estimation of
the vascular parameters vp, Ktrans, and ve in DCE-MRI.
However, DCE-MRI-derived ve has not yet been evaluated
as a true measure of interstitial space in brain tumor, nor
has its relationship to tumor cellularity been examined.
As for the Logan plot, we know of no instance of its use
in DCE-MRI for the estimation of distribution volume
(i.e., plasma volume, vp, plus interstitial volume, ve,
expressed as a fraction), and no examination of its relationship to tumor cellularity. In this study, we introduce
the Logan plot in DCE-MRI for the estimation of distribution volume (VD) in an experimental cerebral tumor and
assess its relationship to tumor cellularity.
Several studies have reported the correspondence of
DCE-MRI-derived vascular parameters with histological
findings, including tumor extracellular space, microvascular density, vascular endothelial growth factor, and
tumor grade (10–12). In a study that is particularly relevant to the considerations of this study, Aref et al. demonstrated a strong correlation between a DCE-MRIderived estimate of extracellular space volume fraction,
and histologically determined extracellular space in a rat
model of chemically induced mammary tumors (10).
Because tumor cellularity, i.e., the number of cells in a
given volume of tumor tissue, is an important factor for
proliferative activity (13), a comparison between noninvasive MRI measures and histology is a significant test
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for validation of the clinical utility of DCE-MRI-derived
parameters. Thus, the objective of this study was to test
the hypothesis that tumor cellularity and a DCE-MRIderived estimate of ve and/or VD were correlated in
experimental cerebral tumor. In the course of examining
the evidence, a number of other measures were examined, but the relation between tumor cellularity and the
DCE-MRI estimated ve and/or VD was the main consideration of this analysis.
THEORY
The Patlak Graphical Analysis and Its Relationship to the
SM
A simplified matrix-based model mathematically equivalent to the Crone-Renkin single-capillary model with no
extra- to intra-vascular efflux was introduced by Patlak
et al. (2). Subsequently, the original Patlak model was
extended to allow for efflux from interstitial space to the
vasculature (3). The extended Patlak model is identical
to the extended Tofts, or consensus model (4), and is
herein referred to as the SM. The SM describes the concentration of CA in tissue after intravenous
administration:
Ct ðtÞ ¼ K

trans

Z

emphasize that model 3 results are identical to the
results produced by the SM, but with the proviso that
the SM has been tested against a reduced model, and
thus more reliably represents the data. Note that, because
an estimate of ve requires the ratio Ktrans/kep, DCE-MRI
estimates of interstitial volume can be reliably performed
only in model 3 regions. The same goes for Logan analysis estimates of VD (see below).
In some regions with CA leakage, but no measurable
back-flux to the vasculature (i.e., kep ¼ 0), only two
parameters, Ktrans and vp, can be estimated. The model
in this case has two parameters and is named model 2.
In normal brain, there is usually little or no measurable
leakage of CA from the microvasculature. In that case,
Ktrans ¼ kep ¼ 0; the one parameter to be estimated is vp
and is accordingly identified as model 1. Model selection proceeded as previously described (6): for each
voxel, the preferred model was selected by the application of an F-test criterion.
The Logan Plot
The tissue and plasma concentration of the CA as a function of time is (7,8);
Rt

t

kep ðttÞ

Cp ðtÞe

dt þ vp Cp ðtÞ;

0

[1]

0

where t is time, Cp(t) and Ct(t) are the time-varying
plasma and tissue concentrations of CA, respectively,
Ktrans is the forward transfer constant of CA between
blood plasma and interstitial space, kep is the reverse
transfer rate constant from the interstitial space to the
vascular compartment, and vp is the vascular plasma volume fraction.
If it is assumed that the change in longitudinal relaxation rate (R1 ¼ 1/T1) is proportional to tissue concentration of the CA (14), the observation equation equivalent
to the SM equation is;
ð1  HctÞDR1t ðtÞ ¼ K trans

Z

t

DR1a ðtÞekep ðttÞ dt þ vp DR1a ðtÞ;

0

[2]
where DR1a and DR1t refer to the subtraction of the precontrast relaxation rate from its post-contrast value at
artery and tissue, respectively, and Hct is the hematocrit
at the level of the microvasculature. In what follows, Hct
was assumed to be 0.45 (15), which may uniformly bias
the results presented below, but will not affect the correRt
lations presented.
DR1a ðtÞekep ðttÞ dt
1t ðtÞ
0
versus
,
Plotting the ratio ð1HctÞDR
DR1a ðtÞ
DR1a ðtÞ
with kep optimized to provide the best fit (in the leastsquares sense) of the model to the data yields the
extended Patlak plot, with a slope of Ktrans and an ordinate intercept of vp. In the tumor, because, within the
duration of the DCE experiment, the CA leaks from the
microvasculature at a high enough rate to begin to equilibrate between the intra- and extra-vascular space, kep
can also be estimated. Because this model fits three
parameters: vp, Ktrans, and kep, it is called model 3. We

Ct ðtÞdt
¼ VD
Ct ðtÞ

Rt

0

Cp ðtÞdt
þ Const
Ct ðtÞ

[3]

where Cp(t) and Ct(t) are the plasma and tissue concentrations of CA, respectively, VD is the distribution volume, and, if an equilibrium has been established
between the vascular compartment and the tissue compartment, Const is a constant. We note that the Logan
plot fits a different portion of the data in DCE-MRI studies than the SM: the SM depends on changes in the
response function (relative to the input function) to estimate the rate parameters Ktrans and kep, while the Logan
analysis demands that the response function does not
change relative to the input function. Thus, the two analyses fit much different portions of the input-response
data, albeit they both require a measure of the data from
time t ¼ 0. Note that, even if kep is not explicitly estitrans
mated (Eq. [2]), but expressed as K ve in the exponent of
the kernel, it is only through dynamic changes that the
term can be estimated.
Because the change in longitudinal relaxation rate is
assumed to be approximately proportional to tissue concentration of the CA, the observation equation for the
Logan plot becomes:
Rt
ð1  Hct Þ

0

DR1t ðtÞdt
¼ VD
DR1t ðtÞ

Rt

0

DR1a ðtÞdt
þ Const
DR1t ðtÞ

[4]

where DR1a(t) and DR1t(t) refers to the subtraction of the
pre-contrast relaxation rate from its post-contrast value at
artery and tumor region, respectively, as a function of
time, and Hct is the hematocrit.
If there is a time after which the plot of
Rt
Rt
DR1t ðtÞdt
DR1a ðtÞdt
ð1  Hct Þ 0 DR1t ðtÞ versus 0 DR1t ðtÞ yields a straight line,
the slope of the fitted straight line gives the distribution
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volume. Once again, the graphical nature of this statement is central to the choice of model. Generally in this
article, data were examined visually for conformance to
the model before selection of the point for starting the fit
of the Logan plot. This procedure can be automated if it
is to be performed on a voxel-by-voxel basis, but a preliminary visual examination of grouped data should be
performed before moving on to a voxel-by-voxel
procedure.
DR1 Calculation Theory
Under the conditions of the experiment, i.e., using a
dual-echo gradient echo sequence (the mgems sequence
in the Agilent VNMRj library), and assuming that the
flip angle is a known constant across the brain of the
rodent, an estimate of the time trace of DR1 can be calculated from the following:


Sðt Þ ¼

eM0 sin ðuÞð1  eTRR1 ðtÞ ÞeTER2 ðtÞ
;
1  cos ðuÞeTRR1 ðtÞ

[5]

where S(t) the signal intensity at time t, E is the detection efficiency, M0 is the equilibrium magnetization of
the protons, u is the tip-angle, TR is the repetition time
between pulses, TE is the echo time (the time between
the center of the excitation pulse and the readout gradient), and R2 (t) is the transverse relaxation rate. Equation
[[5]] can be solved for R1(t):

9
8
SðtÞcos ðuÞ
>
>
>1 
>
<
=
TER
2 sin ðuÞ
eM0 e
1


ln
R1 ðtÞ ¼
[6]
>
TR >
SðtÞ
>
>
:1 
;
TER
eM0 e

2 sin ðuÞ

METHODS
These studies were conducted with the approval of the
Henry Ford Hospital Institutional Animal Care and Use
Committee.
Animal Preparation
U251 Tumor Induction
Athymic rats were inoculated intracerebrally as follows:
animals were anesthetized with 80 mg/kg ketamine and
15 mg/kg xylazine i.m. The surgical zone was swabbed
with Betadine solution, the eyes coated with Lacri-lube,
and the head immobilized in a small animal stereotactic
device (Kopf, Cayunga, CA). After draping, a 1 cm incision was made 2 mm right of the midline and the skull
was exposed. A burr hole was drilled 3.5 mm to the right
of bregma, taking care not to penetrate the dura. A #2701
10 mL Hamilton syringe with a 26 s gauge needle containing U251MG tumor cells freshly harvested from log
phase growth (5  105 in 10 mL of phosphate buffered
solution (PBS)) was lowered to a depth of 3.0 mm and
then raised back to a depth of 2.5 mm. Cells were then
injected at a rate of 0.5 mL/10 s until the entire volume
was injected. Tumors in animals implanted following
this technique grow to about 5 mm diameter by 21 days
post-implantation. On or a few days after day 18, each

animal was anesthetized (isofluorane 4% for knockdown,
0.75–1.5% for maintenance, balance N2O:O2 ¼ 2:1, and
allowed to spontaneously respire). A tail vein was cannulated for the administration of CA. Body temperature

was maintained constant (37 C) with a warm air supply
monitored via an intrarectal type T thermocouple.
MRI Study
DCE-MRI studies were performed using a 7 T magnet in
18 athymic rats at 18 6 3 days after tumor implantation.
The image sets were acquired on a DirectDrive Varian
(now Agilent, Santa Clara, CA) 21 cm bore system with a
32  32 mm field of view. Coils were a Bruker-supplied
volume resonator and a Bruker 2 cm surface coil for rat
brain imaging. High-resolution T1-weighted spin-echo
images were acquired pre- and post-CA (flip angle (FA)


¼ 90 , 180 , matrix 256  192, 27 slices, 0.5 mm thickness, number of echoes (NE) ¼ 1, number of averages
(NA) ¼ 4, TE/TR ¼ 16/800 ms). Before the DCE-MRI
sequence, and immediately after, two Look-Locker
sequences (LL) sequences were run so that a voxel-byvoxel estimate of T1 in the tissue could be made preand post-CA administration. LL sequence parameters

were as follows: FA ¼ 15 , matrix 128  64, five 2.0 mm
slices, no gap. NE ¼ 24 inversion-recovery echoes on 50
ms intervals, TE/TR ¼ 4.0/2000 ms.
The DCE-MRI sequence was a dual-echo gradient-echo
sequence, the “mgems” sequence in the Agilent VnmrJ
library. It acquired 150 image sets at 4.0 s intervals: (FA

¼ 27 , matrix ¼ 128  64, three 2.0 mm slices, NE ¼ 2,
NA ¼ 1, TE1/TE2/TR ¼ 2.0/4.0/60 ms). At image 15 of
the dual-echo gradient-echo sequence Bolus injection of
the CA (Magnevist, Bayer Healthcare Pharmaceuticals,
Wayne, NJ), 0.25 mmol/kg at undiluted concentration,
no flush, was performed by hand push, followed by a
slight draw-back. Following the post-contrast LL
sequence, a Pulsed Gradient Spin-Echo DWI sequence
(matrix 128  64, thirteen 1 mm slices, TR ¼ 1500 ms,
TE ¼ 40 ms, NE ¼ 1, b-values ¼ 0, 1217 s/mm2, gradient
amplitude ¼ 1.07 mT/cm, gradient duration ¼ 10 ms)
was run to generate a parametric map of apparent diffusion coefficient (ADC). These studies carried over from a
previous study that used two CAs of different weights
(Magnevist, then Gd-labeled albumin), with the ADC
studies conducted after the first study in order to save
time and allow for partial clearance of the first CA.
Thus, there may be some small bias in the results (16).
However, because all the studies were conducted in the
same manner, and the results examined through correlation, we judged that inferences drawn from this study
might still be useful.
Histology
At sacrifice, animals were deeply anesthetized with ketamine/xylazine and transcardiacally perfused with saline
followed by 4% paraformaldehyde. After carefully
removing the brains from the skull, they were post-fixed
in same fixative overnight. Coronal sections grossly containing and adjacent to the tumor were obtained using a
rat-brain matrix (Activational Systems, Inc., Warren, MI).
The brain tissue was processed using a VIP Tissue Tek
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Processing center, before embedding. Seven micrometer
sections were cut and placed on Superfrost Plus (Fisher
Scientific) slides and stained with Hematoxylin and
Eosin (H&E) for evaluation of tumor regions of interest
(ROIs). Additional sections were obtained for immunohistochemistry staining. Images were collected using a
Nikon Eclipse E800 Microscope equipped with ACT1C
software.
H&E stained slides were used for cell density measurements. ROIs were chosen in the tumor interior and in
the tumor periphery. The area of the field of view in
each ROI was 4000 mm by 3000 mm. A comparative ROI
was chosen within the contralateral hemisphere, usually
within the caudate putamen. Both 1 low magnification
of the entire coronal section and 10 higher magnification images were collected. Images were imported into
ImageJ (NIH, version1.43u), and converted to 8 bits for
analysis. A thresholding range of 133–193 was used,
depending on the contrast of the H&E staining. The numbers of nuclei were manually counted in a sampling of
regions and compared with the automated count to
ensure accuracy. The particle analysis function used was
set to collect particles in the range of 15–70 mm2. This
was used to count cell nuclei and, therefore, used as the
basis for the cell numbers measures.
Arterial Input Function
Because of the difficulty of directly estimating the arterial input function from MRI data, a radiotracer assaybased input function obtained from a previous investigation (17) was used in the dynamic MRI studies. Nagaraja
et al. (17) have shown that, starting at about two minutes
after injection of CA, the radiological and MRI measures
of blood concentrations of CA track each other very well.
In a number of studies, we examined the tissue response
in a brain area where minimal leakage was known to
occur. It was clear from an examination of the time trace
of DR1 that the early portion of the tissue response curve
did not resemble that of an input function, presumably
because of the dispersion in time of the CA arriving at,
and passing through, the vascular system of the tissue,
and also possibly because of limited water exchange
across the blood-brain barrier. However, during the latter
two-thirds of the study, the tissue response and the radiological standard curve we used appeared to agree, in
line with Nagaraja’s observations. Accordingly, the latter
two-thirds of the time trace of the radiological curve and
the tissue trace of DR1(t) in the caudate putamen were
integrated and used to scale the radiological curve. It
was assumed that: (1) no vascular leakage of CA
occurred in the caudate putamen region contralateral to
the tumor, and (2) the plasma volume of the caudate
putamen was 1% (18). The integrated area of the radiotracer arterial input function was scaled so that its area
was 100 times that of the integrated area of the average
value of DR1(t) in the caudate putamen of the opposite
hemisphere. The 1% figure adopted was larger than
Bereczki’s estimates (0.8–0.9%, Table 5 of the Bereczki
paper (18)) because that work, as the authors noted, estimated only plasma volumes in vessels below 50 mm. All
the volumes estimated in this article are relative to the
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estimate of vp in the caudate putamen; we took the value
of 1% so that relative volumes measured elsewhere
could be easily understood in relation to caudate putamen plasma volumes. This method is a combination of
the reference region approach of Yankeelov et al. (19)
and the original Tofts approach that used a groupaveraged input function (20).
Parameter Estimation—Computational and Statistical
Methods
The analysis of the LL data followed that of Gelman et al.
(21). Briefly, because it was determined that, for a typical
study, the flip angle, u, did not vary by more than a few
percent across a rat brain, a whole-brain estimate of u
was first performed by using a boxcar-smoothed set of
inversion-recovery images and using a Simplex leastsquares minimum finder in three parameters to freely fit
EM0, T1, and u voxel-by-voxel in the smoothed images
(this E was not the same as that of the DCE-MRI
sequence). The flip angle was then fixed at the mean of
its global estimate for the brain and a Simplex minimum
finder in two parameters was used in the unsmoothed
data to produce a voxel-by-voxel estimate of T1 and EM0.
We note that the 2000 ms repetition time of the LL
sequence was too short to allow the inverted magnetization to fully relax to its equilibrium value. An iterative
procedure to estimate the equilibrium value of the magnetization (Mss in Eq. [1] of Gelman et al. (21)) in the
computational estimate of T1 was used to adjust for the
short TR’s, allowing an unbiased estimator of T1 to be
produced.
Consider Eqs. [5] and [6]. Besides R1(t) and R2*(t)
which vary across the experiment, the parameters EM0
and u, which do not vary across the experiment, must be
estimated. Our practice was to estimate R2* using the log
ratio of the first and second echo, to fix the value of u at

27 , and to use maps of R1 constructed from LL maps, in
combination with the amplitude of the DCE data at the
beginning and end of the study, to estimate EM0, as
described in the following paragraph.
The three unknowns in the DCE-MRI sequence (Eq.
[5]) were R1(t), u, and EM0. The measured quantity was
S(t). It was assumed that the tip angle u was known. In
the period before the administration of CA, using the
voxel-by-voxel estimate of R1(t< tinj), produced by the
prior LL measurements, where tinj was the time of CA
injection, the quantity EM0 was estimated using Eq. [5].
Using the post-study estimates of R1 and the last few
points of the DCE-MRI data where the data was changing
slowly, the quantity EM0 was similarly estimated, and
the average of the two estimates was taken. Assuming
that the efficiency for detection did not change after the
injection of CA, this allowed R1(t) to be estimated across
time by means of Eq. [6].
The practice of calculating R1 via LL sequences before
and after the DCE-MRI study allowed EM0 to be estimated under conditions of no CA, and approximately
constant tissue CA concentration. This considerably stabilized the estimate of EM0, and thus of R1(t) because it
fixed the beginning and end points of the R1(t) curve.
The quantity DR1(t) in Eq. [4] was generated by
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FIG. 1. Left: High-resolution post-contrast T1-weighted image. Middle: Corresponding centrally located ADC maps. Right: H&E staining
of a centrally located tissue slice approximating the position of the MRI image.

subtracting the pre-contrast estimate of R1(t) from the
subsequent estimates of R1(t).
All results are reported as the mean 6 standard deviation. The standard error of the means in this sample of
18 studies is the standard deviation divided by 4.24.
The adjusted input function and tissue time trace of
DR1 were used to estimate pharmacokinetic parameters
using the SM, as in Bagher-Ebadian et al. (6). For each
voxel, data points were fitted to model 1, 2, and 3, an Fstatistic was generated to select the preferred model, and
the parameters available under that model were mapped.
However, for the Logan plot, the adjusted input function
and time trace of DR1 in tumor tissue was used to generate the Logan graphical plot. The trend of the plot was
then visually inspected for each animal individually to
choose the starting time point for the straight line fitting
of the plot, after which the slope of the fitted straight
line was measured as an estimate of the distribution
volume.
To estimate the DCE parameters for examining their
correlation to tumor cellularity, a 5  4 pixel ROI was
visually selected on parametric maps to correspond to
the areas from the cell counting on histology. Because
only one slice on MRI data set was used to make the
comparison, anatomical markers such as lateral ventricles, coronal shape, and tumor area comparison (on
high-resolution T1 weighted image) were used to select
the MRI maps and further pinpoint the histological
(Histo) ROI onto the matching parametric maps. Hereafter, this 5  4 pixel ROI is named as the Histo subregion.

Other Statistical Methods
The correlation of the Logan estimate of VD, compared to
the SM VD, was examined by linear regression; their
absolute estimates were assessed for differences via a
paired t-test. Other relationships reported herein (e.g.,
the association between ADC and cell count) were
assessed similarly.
RESULTS
Eighteen DCE-MRI animal studies and corresponding
histological findings were available. All studies were the
second study of a test-retest paradigm, with 24 h
between studies. Test-retest findings are reported elsewhere (22). Mean tumor age was 18 6 3 days. All tumors
were seen clearly on post-contrast T1-weighted images,
ADC maps, and H&E-stained tissue slides.
To introduce the findings, the data from an animal
(#18) studied 21 days post-implantation will be presented. For the example animal, the mean ADC value
(averaged from x, y, and z direction of the center image)
was (9.3 6 2.5)  104 mm2/s. A post-contrast T1weighted image, the corresponding ADC map (averaged
from x, y, and z direction) from the center slice, and an
H&E-stained tissue slide approximating the position of
the MR image of the example animal are shown in Figure 1.
Under the conditions of the experiment, the first pass
of the CA produced a signal decrease due to T2 dephasing in many tissues, particularly in highly vascular
regions of the tumor and in blood. Using the T2 -

FIG. 2. Parametric maps left to right: vp, Ktrans, ve, and model selection. For the model selection map, white is model 3 acceptance,
dark blue is model 2 acceptance, and light blue is model 1 acceptance.
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FIG. 3. Left: H&E-stained tissue
slide corresponding to parametric
map. Right: Parametric map of ve
(only in the model 3 region can
ve be calculated). The white box
drawn on the detail images
shows the ROIs selected for cell
count and ve values.

corrected time trace of dual-echo gradient-echo data, the
pre-contrast R1 values, flip angle and repetition time, the
time trace of DR1 was calculated pixel-by-pixel across
the entire image set. The time trace of DR1 in turn was
used to produce the parametric maps. The parametric
maps for vp, Ktrans, ve, and an F-test based model selection are shown in Figure 2. From the model selection
map, we see that model 1 predominated in normal nonleaky brain tissue, showing little or no leakage of CA.
Model 3 predominated in regions associated with a high
density of tumor cells, as determined by examination of
postmortem tissue slides. Model 2 bordered model 3
regions, showing leakage at reduced rates.
As noted earlier, ve and VD, estimates of interstitial
space can only be measured when CA leaks from the
capillary into the interstitial space in an amount sufficient to measure its back flux to the vasculature. Becaus
the primary goal for this study was to study the relationship between tumor cellularity and DCE-MRI-derived
estimates of interstitial space, only the data from model
3 regions were analyzed. The parameter values in model
3 regions varied considerably from animal to animal,
with the mean values vp ¼ (0.81 6 0.40)%, Ktrans ¼ (2.09
6 0.65)  102 min1, and ve ¼ (6.65 6 1.86)%.
Figure 3 shows the H&E-stained tissue slide with corresponding parametric map of ve. The white box on the
magnified image shows the Histo sub-region chosen for
cell counts and parameter values, respectively. The
mean parameter values estimated in the Histo sub-region
were vp ¼ (0.81 6 0.44)%, Ktrans ¼ (2.08 6 1.45)  102
min1, and ve ¼ (6.99 6 1.45)%.
For each time point, the average DR1 across the points
of the model 3 region and Histo sub-region was determined and used as a measure of the CA concentration
for the purpose of producing a Logan plot. Figure 4(top)
plots the data as an extended Patlak plot in the model 3
region; the slope of the fitted straight line gives Ktrans. In
this example, although the overall fit is excellent (R2 ¼
0.992), there is a clear deviation from linearity in the
early time points. The sources of this deviation are
briefly considered in the Discussion.
Figure 4(bottom) plots the data as a Logan plot in the
same region, with fitting for a straight line between
abscissa values of 90:150 min. In that region, the graph
was linear by inspection. The slope of the fitted line was
0.0897, equivalent to a distribution volume, VD, of
8.97%.

For the sample of 18 animals in the study, the mean
VD measured in model 3 region was (7.21 6 1.98)%,
roughly half that of normal brain parenchyma (23). VD
estimated by two independent methods, SM and Logan
analysis, was highly correlated (r ¼ 0.91, P < 0.001),
where, for the SM method, VD was calculated as the sum
of ve and vp. The mean SM VD (7.46%) did not differ significantly from that of the Logan VD (7.21%) (t ¼ 0.38, N
¼ 18, P ¼ 0.70). This was a confirmatory result, because
the two methods used primarily early data in the SM
pharmacokinetic approach, and primarily late data in the
Logan pharmacokinetic approach.
Cell counts from the Histo sub-region adjacent to the
tumor core region varied from 751 to 3776 with mean
(6standard deviation) 2442 6 840. Figure 5(left) shows a
scatter plot of the SM estimated ve versus tumor cellularity. Figure 5(right) shows the scatter plot of the Logan
plot estimated VD versus tumor cellularity. A linear
regression of tumor cellularity with both ve estimated via
SM and VD via Logan plot showed an inverse relationship, with a strong correlation (r ¼ 0.75 for ve and r ¼
0.76 for VD, P-value < 0.001 for both). The mean SM
estimated distribution volume (plasma volume plus
interstitial volume) was also highly correlated with
tumor cellularity (r ¼ 0.76, P-value < 0.001). Thus, a
measure of interstitial volume fraction (ve) estimated
from the SM, and distribution volume from both SM and
Logan analyses were highly (negatively) correlated with
the tumor cellularity.
The relationship of tumor cellularity and the ADC was
also examined. A significant correlation with ADC (r ¼
0.54, P-value < 0.05) was observed. Notably, this relationship was not as strong as those of the DCE-MRI
measures, although, because the ADC estimate occurred
postcontrast, the result might be weakened.
DISCUSSION
In this study, we measured DCE-MRI parameters using a
dual-echo gradient-echo sequence in a rat model of cerebral glioma at 7 T in order to establish their relationship
to tumor cellularity. The mean DCE parameter values
measured in model 3 regions and/or the Histo subregions were in agreement to those of similar measures
in human glioblastoma using DCE-MRI (6), or CT perfusion (24), and in a rat model of 9L glioma using DCEMRI (25). In this latter reference, however, estimates of
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a study in a rat model of 9L glioma, ve was also found to
be elevated in the tumor core region (25). This result
supports our higher estimates of mean ve and/or VD values in the Histo sub-region comparison with the model 3
region.
Although a number of DCE-MRI studies in glioma
have evaluated blood volume and permeability, only a
few have estimated interstitial volume and its relation to
histological findings. In a study in human glioma, estimation of interstitial volume was helpful in differentiating gliomas from other brain tumors; increasing
interstitial volume tended to correlate with increasing
tumor grades (12). In a study of a rat model of chemically induced mammary tumors, Aref et al. demonstrated
that interstitial volume fraction measured by DCE-MRI
was correlated with histologically measured extracellular
space fraction (10).
In another study in a rat model of 9L tumor, Chenevert
et al. reported an increased volume of water in the interstitial compartment with decrease in cellularity following the chemotherapeutic (Carmustine) intervention (26).
A strong correlation of mean ADC values with tumor cellularity (r ¼ 0.78) was demonstrated, and also that those
values were highly sensitive to changes in cellularity.

FIG. 4. Top: Patlak graphical analysis of the data in the Histo subregion. The solid line shows the linear fit of the data points; the
slope of the line yields the forward transfer constant, Ktrans. Bottom: Logan graphical analysis of the data in the same sub-region.
The solid line shows the linear fit of the data in the range 90:150,
the slope of the line yields an estimate of distribution volume of
about 9%.

ve were much higher than our estimates. Whether the 9L
glioma differs so radically from the U251 model used
herein, or the differing analyses employed produce
much different estimates of kep, remains to be determined. One possibility is that, because all the volume
estimates were indexed to the plasma volume of the caudate putamen, the 1% value we used for plasma volume
fraction in that tissue was too small.
The mean values in the entire model 3 region and the
Histo sub-region did not differ for vp and Ktrans. However
for interstitial volume, the mean values in the Histo subregion were slightly elevated compared with model 3
region; the difference in mean values between two
regions was not significantly different from zero (P ¼
0.57). As noted, the Histo sub-region was typically
selected nearer the tumor core region; that might be a
reason for the higher estimates of ve in the Histo subregion compared with the model 3 region as a whole. In

FIG. 5. Top: Scatter plot of Patlak plot estimates of interstitial volume versus tumor cellularity in the Histo sub-region. The solid line
shows the linear fitting of the plot (r ¼ 0.75, P < 0.001). Bottom:
Scatter plot of Logan plot estimates of distribution volume (VD)
versus tumor cellularity measured in the Histo sub-region. Solid
line shows the linear fitting of the plot (r ¼ 0.76, P < 0.001).

DCE-MRI and Tumor Cellularity in a Rat Model

This increase in interstitial volume could be due to vasogenic edema or shifts of intracellular water to the extracellular space associated with tumor cell necrosis. This
result demonstrates the relationship of tumor cellularity
with interstitial volume and ADC values; a decrease in
cellularity causes the increase in the interstitial volume
and ADC values.
This study has demonstrated the first use of a Logan
plot in DCE-MRI, showing a strong correlation between
tumor cell count and DCE-MRI derived interstitial volume and/or distribution volume estimated from two
independent methods, SM and Logan analyses. The findings imply that the DCE-MRI estimated interstitial volume fraction and/or distribution volume can be used as
a biomarker for tumor cellularity. They support not only
the utility of DCE-MRI in assessing vascular permeability
but also suggest that a measure of tumor cellularity is
available for assessing and potentially classifying gliomas. Thus, DCE-MRI with appropriate model selection
may be a useful tool for both the diagnosis and evaluation of therapeutic response in patients with gliomas.
Given that an estimate of VD is available from the SM’s
estimate of vp þ ve, one might reasonably ask “why generate a Logan plot of VD?” There are two arguments for
the use of the Logan analysis. The first is that, in the
event that a binding potential for a Gd-tagged agent that
does bind to elements of the parenchyma (e.g., gadofosveset (27)) is needed, the operating characteristics of a
compound that does not bind will be useful.
A second, and perhaps more relevant, support for
Logan analysis when a nonbinding CA is an indicator is
that the Logan estimate of VD is likely to be more stable
and less dependent on technique than that of the SM. In
the SM, ve is estimated from the ratio Ktrans/kep, and is
thus a derived parameter. Both of the parameters from
which it is derived are rates: these cannot be estimated
from equilibrium data, but must use those portions of
the data that are dynamically changing with respect to
the input function. Thus, when tissue in a DCE-MRI
study is viewed as an input-response system, the
response measures in the SM and the Logan graphical
analysis fit much different portions of the response
curves for their estimates of distribution volume, albeit
they both require an integral of the input and response
from time zero. In this presentation, it is gratifying that
the two estimates are in good agreement, but we note the
likelihood that SM estimates of distribution volume will
be more dependent on high temporal resolution estimates of the input and tissue response function than
will the Logan analysis. In support of this hypothesis,
we note that, if the data of the example animal, with
intrinsic 4 s time resolution, is binned into 12 s bins, the
Logan estimate of VD changes from 8.9% to 9.2%, while
the SM estimate changes from 11% to 17%. However,
because the operating characteristics of the Logan plot in
DCE-MRI have not been explored, some caution should
be exercised in assuming that it is less sensitive than the
SM to temporal sampling rates.
We note also the evident deviation of the data from
the straight-line extended Patlak fit in the early time
points of Figure 4a (the extended Patlak approach is
equivalent, as we have noted, to the SM). This is despite
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an excellent overall fit of the model to the data (R2 ¼
0.992). Excellent fits of this nature are standard in this
approach; in the 18 studies, the lowest R2 in model 3
grouped data was 0.972, and the group mean was 0.993.
Nevertheless, for the summed data the fit is typically not
perfect. As Figure 4a implies, there may be some additional systematic behavior in the first few minutes of tissue response that is not accounted for in the model.
The candidates for this systematic behavior are numerous. On the luminal side of the microvasculature, it may
be that, in this particular animal, the radiological input
function is not correct; it may be that the heterogeneity
of the tumor in the model 3 region changes the arrival
time and shape of the input function across the regions
of the tumor, and thus, while the radiological input
function is approximately correct, the input function at
the various tumor regions is not; in a related hypothesis,
it may be that the dispersion of the arterial input function due to flow changes the input at the tissue level; it
may be that restricted water exchange in the microvasculature of the tumor changes the apparent longitudinal
relaxivity of the tissue in a concentration-dependent
manner (28–30). In the tissue, it may be that transport of
the CA takes place at a relatively high rate, thus draining
the tissue of CA and violating the model, which requires
that CA, once it extravasates, is reabsorbed in the vasculature of the same voxel. All of these possibilities are
plausible, and in fact may all contribute to the behavior
of the signal in varying amounts.
The two effects that most probably account for the
early deviation of the data from the linearity of the
extended Patlak plot are transvascular water exchange
effects and/or dispersion of the arterial input function
due to flow. Unfortunately, it may not be possible to distinguish between the two.
As to whether water exchange affects the Logan analysis results, Li et al. (31) undertook a DCE-MRI study at
11.7 T in a rat model of cerebral glioma, with sequence
parameters similar to this study, and included water
exchange in their modeling. The dose of CA used in
their study (0.5 mmol/kg) was twice that of ours, but
they concluded that, while transvascular water exchange
was observable, producing a negative bias in the estimate
of plasma volume, transcytolemmal water exchange was
not observable. That is to say, extravasated CA produced
an approximately linear response in tissue DR1. Recent
modeling that incorporates a full three-compartment
water exchange model (32) supports this conclusion; for
the relatively low values of Ktrans observed in cerebral
glioma, transcytolemmal water exchange has little effect.
Thus, in the portion of the curve to which the Logan
plot applies, when the arterial concentration has
decreased, and equilibrated with the extravascular concentration of CA, water exchange effects are probably
minimal. This tends to support the use of the Logan
analysis in MRI, because it can eliminate one potential
source of bias.
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